Amarin Corporation Plc of Dublin, Ireland, has appointed John Thero as its new chief financial officer. Mr Thero will report to Declan Doogan, Amarin’s interim chief executive.
Mr Thero has held senior management positions, including those in finance, for more than 20 years. Most recently he was CFO of ViaCell Inc, a Cambridge, Massachusetts, stem-cell company acquired by PerkinElmer Inc in 2007. Mr Thero began his professional career at Arthur Andersen LLP.
Amarin is a biopharmaceutical company which is developing treatments for cardiovascular disease.
Copyright 2009 Evernow Publishing Ltd